|
|
Article: Unetixs Vascular Forms Strategic Alliance with Endothelix to Provide Earlier, Affordable Detection of Peripheral Arterial Disease.
- Article from:
- Heart Disease Weekly
- Article date:
- November 22, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Thanks to a strategic alliance announced between Unetixs Vascular (http://www.unetixs.com) and Endothelix (http://endothelix.com), early warning of an impending heart attack in asymptomatic patients soon will be possible with an inexpensive, noninvasive diagnostic test performed on the same equipment as a quick, noninvasive diagnostic test for cardiovascular risk assessment and early detection of peripheral arterial disease (PAD) (see also Heart Attack).
Unetixs Vascular, North Kingstown, R.I., has signed an agreement with Endothelix, a Houston-based cardiovascular device company, to incorporate Endothelix's VENDYS[R] (vascular endothelial dysfunction) technology ...